Effect of nasal high flow humidifying oxygen in painless hysteroscopy anesthesia

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100047898

Enrollment

Unknown

Registered

2021-06-27

Start date

2021-06-28

Completion date

Unknown

Last updated

2022-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uterine cavity lesions

Interventions

Test Group:Using nasal high-flow humidified oxygen

Control Group:Oxygen inhalation through nasal catheterization

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: ASA I-II grade; aged 18 to 65 years; BMI<=25kg/m2.

Exclusion criteria

Exclusion criteria: 1. Pregnancy; 2. Allergy to egg yolk or soybean (possible propofol allergy); 3. Severe lung infection or acute asthma attack; 4. Not accompanied by family members; 5. Anaphylactic shock occurs in the book; 6. Change the surgical method.

Design outcomes

Primary

Measure	Time frame
Mean arterial pressure;Heart rate;Respiratory rate;oxyhemoglobin stauration;Body movement;Cough;Sore throat;feel sick and vomit;Bloating;Reflux aspiration;Bronchospasm;Drug dosage;operation time;Wake up time;Intraoperative blood loss;Anesthesia satisfaction survey;	—

Countries

China

Contacts

Public ContactGao Yanchun

University of Science and Technology of China First Affiliated Hospital

35340796@qq.com+86 13866151134

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026